Literature DB >> 8609455

Withaferin A: a new radiosensitizer from the Indian medicinal plant Withania somnifera.

P U Devi1, K Akagi, V Ostapenko, Y Tanaka, T Sugahara.   

Abstract

Withaferin A, a steroidal lactone isolated from the roots of the Indian medicinal plant Withania somnifera, reduced survival of V79 cells in a dose-dependent manner. LD50 for survival was 16 microM. One-hour treatment with a non-toxic dose of 2.1 microM before irradiation significantly enhanced cell killing, giving a sensitizer enhancement ratio (SER) of 1.5 for 37% survival and 1.4 for 10% survival. SER increased with drug dose, but at higher doses the increased lethality appears to be due to two effects-- drug toxicity and radiosensitization. The drug induced a G2/M block, with a maximum accumulation of cells in G2-M phase at 4 h after treatment with 10.5 microM withaferin A in 1 h. The applicability of this drug as a radiosensitizer in cancer therapy needs to be explored.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609455     DOI: 10.1080/095530096146020

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  16 in total

1.  Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.

Authors:  Silvia D Stan; Eun-Ryeong Hahm; Renaud Warin; Shivendra V Singh
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  Withania somnifera and its emerging anti-neoplastic effects.

Authors:  Shailendra Kapoor
Journal:  Inflammopharmacology       Date:  2012-12-08       Impact factor: 4.473

Review 3.  Withaferin A and its potential role in glioblastoma (GBM).

Authors:  Jasdeep Dhami; Edwin Chang; Sanjiv S Gambhir
Journal:  J Neurooncol       Date:  2016-11-11       Impact factor: 4.130

4.  Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.

Authors:  Wipob Suttana; Samlee Mankhetkorn; Wilart Poompimon; Ajay Palagani; Sergey Zhokhov; Sarah Gerlo; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cancer       Date:  2010-05-03       Impact factor: 27.401

5.  Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.

Authors:  Marie L Antony; Joomin Lee; Eun-Ryeong Hahm; Su-Hyeong Kim; Adam I Marcus; Vandana Kumari; Xinhua Ji; Zhen Yang; Courtney L Vowell; Peter Wipf; Guy T Uechi; Nathan A Yates; Guillermo Romero; Saumendra N Sarkar; Shivendra V Singh
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

6.  Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.

Authors:  Silvia D Stan; Yan Zeng; Shivendra V Singh
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

7.  Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.

Authors:  Kirti Vaishnavi; Nishant Saxena; Navjot Shah; Rumani Singh; Kavyashree Manjunath; M Uthayakumar; Shankar P Kanaujia; Sunil C Kaul; Kanagaraj Sekar; Renu Wadhwa
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

8.  Roots of Withania somnifera Inhibit Forestomach and Skin Carcinogenesis in Mice.

Authors:  Bandhuvula Padmavathi; Pramod C Rath; Araga Ramesha Rao; Rana Pratap Singh
Journal:  Evid Based Complement Alternat Med       Date:  2005-02-09       Impact factor: 2.629

9.  Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts.

Authors:  Sunil C Kaul; Yoshiyuki Ishida; Kazuya Tamura; Teruo Wada; Tomoko Iitsuka; Sukant Garg; Mijung Kim; Ran Gao; Shoichi Nakai; Youji Okamoto; Keiji Terao; Renu Wadhwa
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

10.  Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells.

Authors:  Ravikumar Aalinkeel; Zihua Hu; Bindukumar B Nair; Donald E Sykes; Jessica L Reynolds; Supriya D Mahajan; Stanley A Schwartz
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.